Floatz logo

Meropenem

Chronic Bronchitis

Seattle Children's HospitalSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Chronic Bronchitis cohort.

Asset / SponsorPhaseRating
ROPIVACAINE
University Hospital, Clermont-Ferrand
Phase 2B
Amikacin
Seattle Children's Hospital
N/AD
Ciprofloxacin
Seattle Children's Hospital
N/AD
ceftazidime
Seattle Children's Hospital
N/AD
Azithromycin
Seattle Children's Hospital
N/AD

Same molecule, other indications

Meropenem is also rated in:

Pseudomonas infectionDormant
B
Indicative ·
62 / 100
View asset →
pneumoniaDormant
B
Indicative ·
62 / 100
View asset →
sclerosing cholangitisDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →